ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,489 | +6.1% | 13,732 | +20.0% | 0.00% | 0.0% |
| Q2 2023 | $232,407 | +12.9% | 11,443 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $205,802 | -12.7% | 11,283 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $235,628 | -21.2% | 11,394 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $299,000 | -0.7% | 11,444 | -3.5% | 0.00% | 0.0% |
| Q2 2022 | $301,000 | -22.6% | 11,859 | -3.7% | 0.00% | 0.0% |
| Q1 2022 | $389,000 | -23.4% | 12,310 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $508,000 | +16.5% | 12,548 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $436,000 | +25.3% | 12,504 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $348,000 | +0.9% | 12,684 | +3.2% | 0.00% | 0.0% |
| Q1 2021 | $345,000 | +70.8% | 12,296 | +57.7% | 0.00% | +100.0% |
| Q4 2020 | $202,000 | +274.1% | 7,797 | +146.9% | 0.00% | – |
| Q3 2020 | $54,000 | +50.0% | 3,158 | +118.7% | 0.00% | – |
| Q2 2020 | $36,000 | – | 1,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |